Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 

SCSHP Fall Meeting 2024


Friday, October 11, 2024
Location:  Columbia Metropolitan Convention Center, 1101 Lincoln St. Columbia, SC 29201
 
To register, visit: https://scshp.com/meetinginfo.php
 
Fees:
  Pharmacist New Grad/Resident Technician Intern/Student
Member $160 $80 $80 $25
Non-Member $240 $160 $160 $80
 
To view ACPE Activity Announcement: Click here
 
To view the schedule of individual sessions as well as their learning objectives, please scroll to the bottom of the page. 
Clicking on the blue bars will expand the session details!

Date: Oct 11, 2024 08:00 AM - 05:00 PM

CE Hours

6.75

CE Units

0.675

Activity Type

  • Knowledge-Based and Application-Based

Target Audience(s)

  • Pharmacists
  • Pharmacy Technicians

Accreditation(s)

Accreditation Council for Pharmacy Education
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Co-Sponsor(s)

South Carolina Society of Health-System Pharmacists (SCSHP)

Requirements for CE Credit

Participants must sign in upon arrival and have attendance verified.
 
To claim credit for this activity, participants must complete the online program evaluation and must update their accounts to properly reflect their month/day of birth and correct NABP e-Profile ID.  To register with NABP or look up your NABP e-Profile ID, please click on the CPE Monitor logo below to be directed to their site. 
 
Credit that is claimed greater than 60 days from the date of the program will be automatically rejected by the CPE Monitor.  Claiming credit within 30 days of the live program will ensure that any issues with transmission to the CPE Monitor can be rectified in advance of the 60-day deadline.  If you would like a paper statement of credit, you may print an individual statement or a transcript from your NABP e-Profile.
 

 

 

 

 

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Analyze the current landscape of pharmacy school admissions and the factors influencing applicant availability and selection
  2. Identify key changes in pharmacy education resulting from the approval of ACPE “Standards 2025” for the Doctor of Pharmacy program
  3. Differentiate the essential skill sets and characteristics of pharmacy school graduates that facilitate successful integration into the healthcare workforce

Speaker(s)/Author(s)

Giuseppe Gumina, PhD
Dean, Presbyterian College

Julie Sease, PharmD, FCCP, BCPS, CDCES, BCACP
Senior Associate Dean and Professor, University of South Carolina College of Pharmacy

Phillip Hall, PharmD
Dean, MUSC College of Pharmacy

Activity Number

0062-9999-24-177-L99-P/T
Date: 10/11/24
Time: 08:00 AM - 09:00 AM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Discuss the 2024 guideline updates for DKA and HHS
  2. Identify opportunities to update practices matching new guideline updates
 
At the completion of this activity, the pharmacy technician will be able to:
  1. Identify opportunities within transitions of care to prevent re-admissions in patients receiving insulin
  2. Recognize differences between short-acting and long-acting insulin products

Speaker(s)/Author(s)

Abbygail Wilbourn, PharmD, MSPS
PGY2 Critical Care Pharmacy Resident, Prisma Health Upstate

Activity Number

0062-9999-24-178-L01-P/T
Date: 10/11/24
Time: 09:00 AM - 09:30 AM

CE Hours

0.50
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Describe the pathophysiology of vasodilatory shock
  2. Discuss angiotensin II, methylene blue, and hydroxocobalamin usage in vasodilatory shock using primary literature
 
At the completion of this activity, the pharmacy technician will be able to:
  1. Describe the pathophysiology of vasodilatory shock
  2. Describe sterile preparation of angiotensin II, methylene blue, and hydroxocobalamin

Speaker(s)/Author(s)

Abigail Rath, PharmD
PGY2 Critical Care Pharmacy Resident, Medical University of South Carolina Health

Activity Number

0062-9999-24-179-L01-P/T
Date: 10/11/24
Time: 09:30 AM - 10:00 AM

CE Hours

0.50
 

 

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Recall key peer review evidence impacting obesity management
  2. Identify expanded indications and newly approved anti-obesity medications
  3. Summarize important updates in obesity-related clinical practice guidelines
 

Speaker(s)/Author(s)

Reagan Barfield, PharmD, BCPS
Clinical Assistant Professor, USC College of Pharmacy; Ambulatory Clinical Pharmacist, Prisma Health Family Medicine; PGY1 Residency Program Coordinator, Tandem Health - USC

Activity Number

0062-9999-24-180-L01-P/T
Date: 10/11/24
Time: 10:15 AM - 11:00 AM

CE Hours

0.75
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Analyze the appropriateness of the addition of gene therapies to a health-system's formulary
  2. Assemble the necessary team members from throughout a health system to implement best practices for Gene Therapy implementations
  3. Describe best practices for the handling of Gene Therapies in the preparation of products for patient administration
 
At the completion of this activity, the pharmacy technician will be able to:
  1. Analyze the appropriateness of the addition of gene therapies to a health-system's formulary
  2. Identify appropriate storage and handling of Gene Therapies and the importance of monitoring and security systems
  3. Describe best practices for the handling of Gene Therapies in the preparation of products for patient administration

Speaker(s)/Author(s)

Corey Jennings, MBA, CHFP
Senior Financial Analyst, Prisma Health

Eric Chmielewski, PharmD, MS, BCOP
Director, Pharmacy Business Services, McLeod Health

Harrison Jozefczyk, PharmD, MS
Director, Pharmacy Oncology, Prisma Health

Activity Number

0062-9999-24-181-L01-P/T
Date: 10/11/24
Time: 11:00 AM - 12:15 PM

CE Hours

1.25
 

 

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Describe pharmacist impact on commonly encountered clinical scenarios
  2. Provide an example of appropriate continuity of care for commonly encountered clinical scenarios
  3. Recognize medication safety principles in commonly encountered clinical scenarios
  4. Describe the importance of utilizing evidence-based medicine in commonly encountered clinical scenarios
 

Activity Number

0062-9999-24-182-L01-P/T
Date: 10/11/24
Time: 01:30 PM - 02:30 PM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Discuss the importance of correct PPE use when handling hazardous substances in the pharmacy
  2. Interpret current studies that highlight hazardous risks to healthcare workers
  3. Analyze the effectiveness of PPE in hazardous sterile compounding
  4. Identify the improvements made to healthcare worker safety with the publishing of USP chapters <797> and <800>

Speaker(s)/Author(s)

Giuliana Lyke, PharmD, BCSCP, DPLA
Pharmacist in Charge, Prisma Health Cancer Institute-Midlands

Savannah Mancuso-Noyes, PharmD, BCSCP
Consultant Pharmacist, Prisma Health Infusion Center

Activity Number

0062-9999-24-183-L05-P/T
Date: 10/11/24
Time: 02:45 PM - 03:45 PM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Recall the pathophysiology of endometriosis and associated complications
  2. Differentiate pharmaceutical agents utilized for the management of endometriosis-associated pain
  3. Assess various clinical trials used in the selection of the pharmaceutical agents for endometriosis-associated pain
 
At the completion of this activity, the pharmacy technician will be able to:
  1. Recall the pathophysiology of endometriosis and associated complications
  2. Identify pharmaceutical agents utilized for the management of endometriosis-associated pain
  3. Relate adverse effects of medications used to treat endometriosis with incidence reported in clinical trials

Speaker(s)/Author(s)

Jacob Krissinger, PharmD Candidate 2025
Student, University of South Carolina, College of Pharmacy

Julia Geith, PharmD Candidate 2025
Student, University of South Carolina, College of Pharmacy

Activity Number

0062-9999-24-184-L01-P/T
Date: 10/11/24
Time: 03:45 PM - 04:30 PM

CE Hours

0.75